all

(redirected from Acute lymphoblastic leukaemia)
Also found in: Dictionary, Thesaurus, Medical, Financial.

all

adjective complete, each and every, full, global, integral, nothing but, only, perfect, the sum of, total, universal, wholly

all

noun aggregate, all and sundry, allness, collectiveness, completeness, complexus, entireness, entirety, everyone, everything, fullness, gross amount, indivisibility, intactness, integer, integrality, one and all, sum, sum total, total, totality, undividedness, universality, whole, wholeness
See also: complete, entirety, sum, total, whole
References in periodicals archive ?
We conclude that cytogenetics play an important role in management and prognosis of B-cell Acute Lymphoblastic leukaemia with hypotriploid chromosome number.
Specific extra chromosomes occur in a modal number dependent pattern in pediatric acute lymphoblastic leukaemia.
Prospective outcome data on 267 unselected adult patients with Philadelphia-chromosome positive acute lymphoblastic leukaemia confirms superiority of allogeneic transplantation over chemotherapy in the pre-imatinib era: results from the international ALL trial MRC UKALLXII/ECOG2993.
Impaired pubertal growth in acute lymphoblastic leukaemia.
Incidence and morbidity of infection by hepatitis C virus in children with acute lymphoblastic leukaemia.
Ovarian function following the treatment of childhood acute lymphoblastic leukaemia.
Male fertility in long-term survivors of childhood acute lymphoblastic leukaemia.
Translation of cure for acute lymphoblastic leukaemia to all children.
Novel multiagent chemotherapy for bone marrow relapse of pediatric acute lymphoblastic leukaemia.
Molecular detection of minimal residual disease is a strong predictive factor of relapse in childhood B-lineage acute lymphoblastic leukaemia with medium risk features.
PharmaMar's clinical portfolio currently includes Yondelis(TM) in phase II clinical trials (co-developed with Johnson & Johnson Pharmaceutical Research & Development), designated Orphan Drug for STS by the EMEA in 2001 and Orphan Drug for ovarian cancer in 2003; Aplidin(R), in phase II, designated Orphan Drug for acute lymphoblastic leukaemia in 2003; Kahalalide F in phase II and ES-285 in phase I clinical trials.
Full browser ?